View 3 reports from 1 analysts offering long term price targets
for Clean Science & Technology Ltd..
Clean Science & Technology Ltd. has an average target of 1659.00. The consensus estimate
represents a downside of -0.84%
from the last price of 1673.05.
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
Clean Science (CLEAN) reported a beat on our revenue, however sharp rise in raw materials resulted in gross margin collapsing to 65% vs. our expectation of 70%. Despite higher absolute gross margin, higher operating expenditure led to in-line EBITDA (margin at 42.1% v/s 49.8% in 3QFY21 and 44.9% in 2QFY22). The Pharma and FMCG Chemicals segment performed better while the Performance Chemicals segment saw weak performance in the quarter....
Sarfraz Bhimani, CFA - Research Analyst (Sarfraz.Bhimani@MotilalOswal.com) Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P; Capital....
Raised Rs.464 crs from anchor investors ahead of its initial public offer Primary focus on export growth by gaining access to new markets. Has a strong established Market Position Revenue generated by top 10 customers as of March FY21 represented 48% of total revenue. The Operations of the company in terms of Revenue, EBIDTA, and PAT has registered a CAGR growth of 14%, 38% &43% respectively during FY19-FY21. It is offered at P/E of 42 FY21 earnings which is below industry average of 55x, therefore we...
Incorporated in 2003, Clean Science and Technology manufactures critical specialty chemicals such as performance chemicals (MEHQ, BHA, AP), pharmaceutical intermediates (Guaiacol, DCC), and FMCG chemicals (4MAP and Anisole). The company's products are used as key starting level materials, as inhibitors, or as additives, by customers, for products sold in regulated markets. Key customers include Bayer AG, SRF Ltd, Gennex Laboratories, Nutriad International NV and Vinati Organics. It has two certified production facilities with a combined installed capacity of 29,900...
Compare Stocks
